Jim Greenwood announced as new board chair of BIO Ventures for Global Health
BIO is the largest biotech industry in the world, representing academic institutions, biotech companies and related organizations in more than 30 countries, including the U.S.
"Jim's leadership of the BVGH Board is an important signal to the global health community of BIO member companies' ongoing commitment to solving global health issues, including the eradication of neglected infectious diseases such as Ebola," BVGH President Jennifer Dent said.
Greenwood fills the three-year board chair position and succeeds Don Joseph, former CEO and chairman of BVGH.
"BVGH's mission to spur new life science research and partnerships in global health is in perfect alignment with BIO's efforts to address health challenges facing developing and emerging countries throughout the world," Greenwood said. "BVGH has rapidly executed an impressive level of research partnerships and innovative scientific programs over the past three years. I look forward to working with and advising BVGH's team as we increase patient access to biologic therapies, cures, vaccines and diagnostics that are helping patients around the globe who are suffering from cancer, HIV/AIDS and numerous other serious diseases and conditions."